FineMark National Bank & Trust’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-27,500
Closed -$203K 466
2021
Q3
$203K Hold
27,500
0.01% 422
2021
Q2
$366K Sell
27,500
-47,500
-63% -$467K 0.01% 338
2021
Q1
$567K Buy
+75,000
New +$846K 0.02% 269

Other funds holding CLOV

FineMark National Bank & Trust's CLOV Position: Q4 2021 in Review

FineMark National Bank & Trust sold out of Clover Health Investments (CLOV) in Q4 2021, closing a stake of 27,500 shares — an estimated $203K sold.

FineMark National Bank & Trust first reported a position in CLOV in Q1 2021 and held it in 3 quarters. The position peaked at $567K in Q1 2021. 161 funds tracked by Wall St. Rank hold CLOV as of Q4 2021.

  • FineMark National Bank & Trust reported no remaining Clover Health Investments position as of Q4 2021 after selling out during the quarter.
  • FineMark National Bank & Trust sold 27,500 Clover Health Investments shares in Q4 2021, an estimated $203K.
  • FineMark National Bank & Trust first reported a position in Clover Health Investments in Q1 2021 and held it in 3 quarters.
  • FineMark National Bank & Trust's Clover Health Investments position peaked at $567K in Q1 2021.
  • 161 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2021.

Based on FineMark National Bank & Trust's 13F filing for Q4 2021, filed 14 Feb 2022.